现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
30期
3329-3331
,共3页
姚永强%韩雪%曹铭谦%方红%解继平
姚永彊%韓雪%曹銘謙%方紅%解繼平
요영강%한설%조명겸%방홍%해계평
乳腺癌%Claudin-3%淋巴结转移
乳腺癌%Claudin-3%淋巴結轉移
유선암%Claudin-3%림파결전이
breast cancer%Claudin-3%lymph nodes metastasis
目的:探讨Claudin-3在不同转移淋巴结个数乳腺癌患者中表达的差异。方法将128例乳腺癌组织标本按淋巴结转移个数分组,转移淋巴结个数<4个为A组,≥4个为B组,2组各64例。应用实时定量逆转录聚合酶链反应( RT-PCR)检测2组乳腺癌组织Claudin-3的表达水平并进行比较。结果 A组Claudin-3 mRNA表达低于B组,2组比较有显著性差异(P<0.05)。不同年龄、激素受体状态、CerbB-2、p53、ki67和组织学分级患者Claudin-3表达水平比较差异均无统计学意义(P均>0.05)。结论 Claudin-3表达上调可促进乳腺癌的淋巴结转移,与预后不良有关。
目的:探討Claudin-3在不同轉移淋巴結箇數乳腺癌患者中錶達的差異。方法將128例乳腺癌組織標本按淋巴結轉移箇數分組,轉移淋巴結箇數<4箇為A組,≥4箇為B組,2組各64例。應用實時定量逆轉錄聚閤酶鏈反應( RT-PCR)檢測2組乳腺癌組織Claudin-3的錶達水平併進行比較。結果 A組Claudin-3 mRNA錶達低于B組,2組比較有顯著性差異(P<0.05)。不同年齡、激素受體狀態、CerbB-2、p53、ki67和組織學分級患者Claudin-3錶達水平比較差異均無統計學意義(P均>0.05)。結論 Claudin-3錶達上調可促進乳腺癌的淋巴結轉移,與預後不良有關。
목적:탐토Claudin-3재불동전이림파결개수유선암환자중표체적차이。방법장128례유선암조직표본안림파결전이개수분조,전이림파결개수<4개위A조,≥4개위B조,2조각64례。응용실시정량역전록취합매련반응( RT-PCR)검측2조유선암조직Claudin-3적표체수평병진행비교。결과 A조Claudin-3 mRNA표체저우B조,2조비교유현저성차이(P<0.05)。불동년령、격소수체상태、CerbB-2、p53、ki67화조직학분급환자Claudin-3표체수평비교차이균무통계학의의(P균>0.05)。결론 Claudin-3표체상조가촉진유선암적림파결전이,여예후불량유관。
Objective It is to investigate the difference of Claudin -3 expression between breast cancer patients had differ-ent number of metastatic lymph nodes .Methods 128 breast cancer tissue specimens were divided into two groups according to the number of metastatic lymph nodes , the number of metastatic lymph nodes <4 in Group A, and ≥4 in Group B, there were 64 cases in each group .The different expression of Claudin -3 in Group A and B were examined by RT -PCR and com-pared.Results The level of Claudin -3 was significantly lower in Group A than that in Group B , there was significant differ-ence (P<0.05).There were no significant differences in patiens with different age , status of hormone receptor, CerB-2, p53, ki67 and histologial type (all P>0.05).Conclusion Increasing expression of Claudin -3 is associated with the metas-tasis of breast cancer and lead to poor prognosis.